# AmbioPharm, Inc – FDA Inspection, Jul 5, 2017

Source: https://www.keypedia.com/records/fda_inspections/ambiopharm-inc/034acc5a-11fe-467b-89ef-f72b1cbff8e4
Source feed: FDA_Inspections

> FDA inspection 1018621 of AmbioPharm, Inc, July 05, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018621
- Company Name: AmbioPharm, Inc
- Inspection Date: 2017-07-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1196909 - 2023-02-09](https://www.keypedia.com/records/fda_inspections/ambiopharm-inc/1876e58a-256b-4566-b2d8-992e46cd34e2)
- [FDA Inspection 900896 - 2014-10-09](https://www.keypedia.com/records/fda_inspections/ambiopharm-inc/2c31fbf0-16c7-41b7-b568-fb6648633d40)
- FDA Inspection 826320 - 2013-03-28
- FDA Inspection 740844 - 2011-08-16
- FDA Inspection 546751 - 2008-11-04

## Related Officers

- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/sonya-m-edmonds/a38fad3f-f664-4c52-8e50-78782f56ff18)

Company: https://www.keypedia.com/companies/ambiopharm-inc/6a51f093-2f5b-433d-8e97-8e33820a50bf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c